Critical review uncovers dual appearance and functional pathways linking foot appearance to self-esteem in clinical populations, suggesting the need for integrated psychosocial assessment tools.
Research on body image has developed sophisticated models of appearance evaluation, body appreciation, social appearance anxiety, and psychosocial functioning. Research on foot disorders, by contrast, has largely relied on measures of pain, mobility, footwear, and health-related quality of life. The relationship between perceived foot appearance, body image, and global self-esteem therefore remains conceptually plausible but empirically under-specified. This article critically synthesizes a fixed corpus of 27 verified, openly traceable scientific and methodological sources published between 1965 and 2026, with the principal analytical window covering 1995–2026. A structured critical review, evidence mapping, synthesis without meta-analysis, and conceptual modeling were used. Studies were classified as direct evidence, foot- or nail-specific psychosocial evidence, transferable theory and measurement, or methodological/framework sources. The synthesis yields four results. First, direct studies connecting foot appearance with body image or self-evaluation are few and context-bound, whereas most evidence uses quality of life, footwear, social interaction, embarrassment, or function as proxies. Second, the evidence supports an analytical dual-path model: an appearance–social-evaluation pathway and a function–participation pathway may converge on body-image-related quality of life and self-evaluation. Third, no instrument in the reviewed corpus simultaneously covers local foot-appearance appraisal, general body image, global self-esteem, social appearance anxiety, avoidance behavior, and foot function. Fourth, visibility, footwear norms, occupational context, culture, symptoms, and infection-related stigma delimit the model’s applicability. The contribution lies in separating construct levels and evidence types rather than asserting a universal effect. The review does not establish prevalence, causality, or a pooled effect size; its model and proposed assessment set require prospective, culturally diverse validation.
No takes yet. Share an insight, caveat, or question.
A 2026 study studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: